BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Fish and Richardson

Generated: March 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021998

« Back to Dashboard

NDA 021998 describes PLAN B ONE-STEP, which is a drug marketed by Fdn Consumer and is included in one NDA. It is available from five suppliers. Additional details are available on the PLAN B ONE-STEP profile page.

The generic ingredient in PLAN B ONE-STEP is levonorgestrel. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 021998
Applicant:Fdn Consumer
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 021998
Ingredient-typeProgesterone Congeners
Physiological EffectInhibit Ovum Fertilization
Medical Subject Heading (MeSH) Categories for 021998
Suppliers and Packaging for NDA: 021998
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PLAN B ONE-STEP levonorgestrel TABLET;ORAL 021998 NDA Rebel Distributors Corp 21695-973 E 21695-973-01
PLAN B ONE-STEP levonorgestrel TABLET;ORAL 021998 NDA A-S Medication Solutions 50090-1141 N 50090-1141-0

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Jul 10, 2009TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.